ParshallM.B., SchwartzsteinR.M., AdamsL.An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea.Am J Respir Crit Care Med2012; 185(4): 435–452. doi: 10.1164/rccm.201111–2042ST.
2.
DormanS., JolleyC., AbernethyA.Researching breath-lessness in palliative care: consensus statement of the National Cancer Research Institute Palliative Care Breathless-ness Subgroup.Palliat Med2009; 23(3): 213–227. doi: 10.1177/0269216309102520.
3.
DudgeonD.J.Managing dyspnea and cough.Hematol Oncol Clin North Am2002; 16(3): 557–577, viii.
4.
BauseweinC., BoothS., GyselsM.Understanding breath-lessness: cross-sectional comparison of symptom burden and palliative care needs in chronic obstructive pulmonary disease and cancer.J Palliat Med2010; 13(9): 1109–1118. doi: 10.1089/jpm. 2010.0068.
5.
GyselsM.H., HigginsonI.J.The lived experience of breathless-ness and its implications for care: a qualitative comparison in cancer, COPD, heart failure and MND.BMC Palliat Care2011; 10: 15. doi: 10.1186/1472–684X-10-15.
6.
MalikF.A., GyselsM., HigginsonI.J.Living with breathlessness: a survey of caregivers of breathless patients with lung cancer or heart failure.Palliat Med2013; 27(7): 647–656. doi: 10.1177/0269216313488812.
KavalieratosD., KamalA.H., AbernethyA.P.Comparing unmet needs between community-based palliative care patients with heart failure and patients with cancer.J Palliat Med2014; 17(4): 475–481. doi: 10.1089/jpm.2013.0526.
9.
SolanoJ.P., GomesB., HigginsonI.J.A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease.J Pain Symptom Manage2006; 31(1): 58–69.
10.
JanssenD.J., SpruitM.A., Uszko-LencerN.H.Symptoms, comorbidities, and health care in advanced chronic obstructive pulmonary disease or chronic heart failure.J Palliat Med2011; 14(6): 735–743. doi: 10.1089/jpm.2010.0479.
11.
JanssenD.J., WoutersE.F., ScholsJ.M.Self-perceived symptoms and care needs of patients with severe to very severe chronic obstructive pulmonary disease, congestive heart failure or chronic renal failure and its consequences for their closest relatives: the research protocol.BMC Palliat Care2008; 7: 5. doi: 10.1186/1472–684X-7-5.
12.
BeynonT., GomesB., MurtaghF.E.How common are palliative care needs among older people who die in the emergency department?BMJ Support Palliat Care2011; 1(2): 184–188. doi: 10.1136/bmjspcare.2009.090019rep.
13.
KaneP.M., VinenK., MurtaghF.E.Palliative care for advanced renal disease: a summary of the evidence and future direction.Palliat Med2013; 27(9): 817–821. doi: 10.1177/0269216313491796.
14.
MurtaghF.E., Addington-HallJ.M., HigginsonI.J.End-stage renal disease: a new trajectory of functional decline in the last year of life.J Am Geriatr Soc2011; 59(2): 304–308. doi: 10.1111/j.1532-5415.2010.03248.x.
15.
BauseweinC., BoothS., GyselsM.Individual breathless-ness trajectories do not match summary trajectories in advanced cancer and chronic obstructive pulmonary disease: results from a longitudinal study.Palliat Med2010; 24(8): 777–786. doi: 10.1177/0269216310378785.
16.
SeowH., BarberaL., SutradharR.Trajectory of performance status and symptom scores for patients with cancer during the last six months of life.J Clin Oncol2011; 29(9): 1151–1158. doi: 10.1200/JCO.2010.30.7173.
17.
FrostadA., SoysethV., HaldorsenT.Impact of respiratory symptoms on lung cancer: 30-year follow-up of an urban population.Lung Cancer2008; 60(1): 22–30.
FrostadA., SoysethV., AndersenA.Respiratory symptoms as predictors of all-cause mortality in an urban community: a 30-year follow-up.J Intern Med2006; 259(5): 520–529.
20.
BarberaL., AtzemaC., SutradharR.Do patient-reported symptoms predict emergency department visits in cancer patients? A population-based analysis.Ann Emerg Med2013; 61(4): 427–437.e5. doi: 10.1016/j.annemergmed.2012.10.010.
21.
BarberaL., TaylorC., DudgeonD.Why do patients with cancer visit the emergency department near the end of life?CMAJ2010; 182(6): 563–568. doi: 10.1503/cmaj.091187.
22.
CurrowD.C., AbernethyA.P.Breathlessness in an age of non-communicable diseases.Curr Opin Support Palliat Care2012; 6(2): 127–128. doi: 10.1097/SPC.0b013e3283537d26.
23.
BoothS., MoosaviS.H., HigginsonI.J.The etiology and management of intractable breathlessness in patients with advanced cancer: a systematic review of pharmacological therapy.Nat Clin Prac Oncol2008; 5(2): 90–100. doi: 10.1038/ncponc1034.
24.
McCannonJ., TemelJ.Comprehensive management of respiratory symptoms in patients with advanced lung cancer.J Support Oncol2012; 10(1): 1–9. doi: 10.1016/j.suponc.2011.07.002.
25.
BoothS., MoffatC., BurkinJ.Nonpharmacological interventions for breathlessness.Curr Opin Support Palliat Care2011; 5(2): 77–86. doi: 10.1097/SPC.0b013e3283460c93.
26.
KillianK., CampbellM.Dyspnea. In: RoussosC., MacklemP.T., editors. The thorax.2nd ed. Part B: Applied physiology. New York: Marcel Dekker; 1995. (Lung biology in health and disease; vol. 29).
27.
JolleyC.J., MoxhamJ.A physiological model of patient-reported breathlessness during daily activities in COPD.Eur Respir Rev2009; 18(112): 66–79. doi: 10.1183/09059180.00000809.
28.
SinderbyC., BeckJ., SpahijaJ.Voluntary activation of the human diaphragm in health and disease.J Appl Physiol1998; 85(6): 2146–2158.
29.
DuivermanM.L., de BoerE.W.J., van EykernL.A.Respiratory muscle activity and dyspnea during exercise in chronic obstructive pulmonary disease.Respir Physiol Neurobiol2009; 167(2): 195–200. doi: 10.1016/j.resp.2009.04.018.
30.
ReillyC.C., WardK., JolleyC.J.Neural respiratory drive, pulmonary mechanics and breathlessness in patients with cystic fibrosis.Thorax2011; 66(3): 240–246. doi: 10.1136/thx.2010.142646.
31.
O'DonnellD.E., HamiltonA.L., WebbK.A.Sensory-mec-hanical relationships during high-intensity, constant-work-rate exercise in COPD.J Appl Physiol2006; 101(4): 1025–1035.
32.
O'DonnellD.E., BanzettR.B., Carrieri-KohlmanV.Patho-physiology of dyspnea in chronic obstructive pulmonary disease: a roundtable.Proc Am Thorac Soc2007; 4(2): 145–168.
33.
HerigstadM., HayenA., WiechK.Dyspnoea and the brain.Respir Med2011; 105(6): 809–817. doi: 10.1016/j.rmed.2010.12.022.
34.
von LeupoldtA., DahmeB.Cortical substrates for the perception of dyspnea.Chest2005; 128(1): 345–354.
35.
BanzettR.B., MulnierH.E., MurphyK.Breathlessness in humans activates insular cortex.Neuroreport2000; 11(10): 2117–2120.
36.
O'DonnellD.E., HongH.H., WebbK.A.Respiratory sensation during chest wall restriction and dead space loading in exercising men.J Appl Physiol (1985)2000; 88(5): 1859–1869.
37.
HigginsonI.J., SimonS.T., BenaliaH.Which questions of two commonly used multidimensional palliative care patient reported outcome measures are most useful? Results from the European and African PRISMA survey.BMJ Support Palliat Care2012; 2(1): 36–42. doi: 10.1136/bmjspcare-2011-000061.
38.
BauseweinC., BoothS., GyselsM.Individual breathlessness trajectories do not match summary trajectories in advanced cancer and chronic obstructive pulmonary disease: results from a longitudinal study.Palliat Med2010; 24(8): 777–786. doi: 10.1177/0269216310378785.
39.
SimonS.T., BauseweinC., SchildmannE.Episodic breathlessness in patients with advanced disease: a systematic review.J Pain Symptom Manage2013; 45(3): 561–578. doi: 10.1016/j.jpainsymman.2012.02.022.
40.
SimonS.T., HigginsonI.J., BenaliaH.Episodes of breathlessness: types and patterns — a qualitative study exploring experiences of patients with advanced diseases.Palliat Med2013; 27(6): 524–532. doi: 10.1177/0269216313480255.
41.
BrooksD., SolwayS., GibbonsW.J.ATS statement on six-minute walk test.Am J Respir Crit Care Med2003; 167(9): 1287.
42.
SinghS.J., MorganM.D., ScottS.Development of a shuttle walking test of disability in patients with chronic airways obstruction.Thorax1992; 47(12): 1019–1024.
43.
RevillS.M., MorganM.D.L., SinghS.J.The endurance shuttle walk: a new field test for the assessment of endurance capacity in chronic obstructive pulmonary disease.Thorax1999; 54(3): 213–222.
44.
MesquitaR., JanssenD.J., WoutersE.F.Within-day test-retest reliability of the Timed Up & Go test in patients with advanced chronic organ failure.Arch Phys Med Rehabil2013; 94(11): 2131–2138. doi: 10.1016/j.apmr.2013.03.024.
45.
KonS.S., CanavanJ.L., NolanC.M.The 4-metre gait speed in COPD: responsiveness and minimal clinically important difference.Eur Respir J2013; 43(5): 1298–1305. doi: 10.1183/09031936. 00088113.
46.
KonS.S., PatelM.S., CanavanJ.L.Reliability and validity of 4-metre gait speed in COPD.Eur Respir J2013; 42(2): 333–340. doi: 10.1183/09031936.00162712.
47.
JonesS.E., KonS.S., CanavanJ.L.The five-repetition sit-to-stand test as a functional outcome measure in COPD.Thorax2013; 68(11): 1015–1020. doi: 10.1136/thoraxjnl-2013-203576.
48.
MaddocksM., PetrouA., SkipperL.Validity of threeaccelerometers during treadmill walking and motor vehicle travel.Br J Sports Med2010; 44(8): 606–608. doi: 10.1136/bjsm.2008. 051128.
49.
MaddocksM., ByrneA., JohnsonC.D.Physical activity level as an outcome measure for use in cancer cachexia trials: a feasibility study.Support Care Cancer2010; 18(12): 1539–1544. doi: 10.1007/s00520-009-0776-2.
50.
WeingaertnerV., ScheveC., GerdesV.Breathlessness, functional status, distress, and palliative care needs over time in patients with advanced chronic obstructive pulmonary disease or lung cancer: a cohort study.J Pain Symptom Manage; forthcoming 2014. doi: 10.1016/j.jpainsymman.2013.11.011.
51.
MaddocksM., WilcockA.Exploring physical activity level in patients with thoracic cancer: implications for use as an outcome measure.Support Care Cancer2012; 20(5): 1113–1116. doi: 10.1007/s00520-012-1393-z.
52.
FerriolliE., SkipworthR.J., HendryP.Physical activity monitoring: a responsive and meaningful patient-centered outcome for surgery, chemotherapy, or radiotherapy?J Pain Symptom Manage2012; 43(6): 1025–1035. doi: 10.1016/j.jpainsymman. 2011.06.013.
53.
CurrowD.C., AbernethyA.P., JohnsonM.J.Activity as a measure of symptom control.J Pain Symptom Manage2012; 44(5): e1–2. doi: 10.1016/j.jpainsymman.2012.07.005.
54.
JolleyC.J., LuoY.M., SteierJ.Neural respiratory drive in healthy subjects and in COPD.Eur Respir J2009; 33(2): 289–297. doi: 10.1183/09031936.00093408.
55.
MurphyP.B., KumarA., ReillyC.Neural respiratory drive as a physiological biomarker to monitor change during acute exacerbations of COPD.Thorax2011; 66(7): 602–608. doi: 10.1136/thx.2010.151332.
56.
ReillyC.C., JolleyC.J., ElstonC.Measurement of parasternal intercostal electromyogram during an infective exacerbation in patients with cystic fibrosis.Eur Respir J2012; 40(4): 977–981.
57.
BauseweinC., BoothS., GyselsM.Non-pharmacological interventions for breathlessness in advanced stages of malignant and non-malignant diseases.Cochrane Database Syst Rev2008; 2: CD005623. doi: 10.1002/14651858.CD005623.pub2.
58.
DonaldsonA.V., MaddocksM., MartoliniD.Muscle function in COPD: a complex interplay.Int J Chron Obstruct Pulmon Dis2012; 7: 523–535. doi: 10.2147/COPD.S28247.
59.
MaddocksM., TaylorV., KlezlovaR.When will I get my breath back? Recovery time of exercise-induced breathless-ness in patients with thoracic cancer.Lung Cancer2012; 76(1): 128–129. doi: 10.1016/j.lungcan.2012.01.003.
60.
MaddocksM., GaoW., HigginsonI.J.Neuromuscular electrical stimulation for muscle weakness in adults with advanced disease.Cochrane Database Syst Rev2013; 1: CD009419. doi: 10.1002/14651858.CD009419.pub2.
61.
SillenM.J.H., FranssenF.M.E., DelbressineJ.M.L.Efficacy of lower-limb muscle training modalities in severely dyspnoeic individuals with COPD and quadriceps muscle weakness: results from the DICES trial.Thorax2014; 69(6): 525–531. doi: 10.1136/thoraxjnl-2013-204388.
62.
MaddocksM., HallidayV., ChauhanA.Neuromuscular electrical stimulation of the quadriceps in patients with non-small cell lung cancer receiving palliative chemotherapy: a randomized phase II study.PloS One2013; 8(12): e86059. doi: 10.1371/journal.pone.0086059.
63.
WilcockA., MaddocksM., LewisM.Symptoms limiting activity in cancer patients with breathlessness on exertion: ask about muscle fatigue.Thorax2008; 63(1): 91–92.
64.
CelliB.R., RassuloJ., MakeB.J.Dyssynchronous breathing during arm but not leg exercise in patients with chronic airflow obstruction.New Engl J Med1986; 314(23): 1485–1490.
65.
PanL., GuoY.Z., YanJ.H.Does upper extremity exercise improve dyspnea in patients with COPD? A meta-analysis.Respir Med2012; 106(11): 1517–1525. doi: 10.1016/j.rmed.2012.08.002.
66.
BentleyR., HussainA., MaddocksM.Occupational therapy needs of patients with thoracic cancer at the time of diagnosis: findings of a dedicated rehabilitation service.Support Care Cancer2013; 21(6): 1519–1524. doi: 10.1007/s00520-012-1687-1.
67.
ProbstV.S., TroostersT., CoosemansI.Mechanisms of improvement in exercise capacity using a rollator in patients with COPD.Chest2004; 126(4): 1102–1107.
68.
VaesA.W., AnnegarnJ., MeijerK.The effects of a “new” walking aid on exercise performance in patients with COPD: a randomized crossover trial.Chest2012; 141(5): 1224–1232. doi: 10.1378/chest.11–1076.
69.
JohnsonM.J., AbernethyA.P., CurrowD.C.Gaps in the evidence base of opioids for refractory breathlessness.A future work plan? J Pain Symptom Manage2012; 43(3): 614–624. doi: 10.1016/j.jpainsymman.2011.04.024.
70.
JohnsonM.J., BlandJ.M., OxberryS.G.Opioids for chronic refractory breathlessness: patient predictors of beneficial response.Eur Respir J2013; 42(3): 758–766. doi: 10.1183/0903 1936. 00139812.
71.
RockerG., YoungJ., DonahueM.Perspectives of patients, family caregivers and physicians about the use of opioids for refractory dyspnea in advanced chronic obstructive pulmonary disease.CMAJ2012; 184(9): E497–E504. doi: 10.1503/cmaj.111758.
72.
CurrowD.C., McDonaldC., OatenS.Once-daily opioids for chronic dyspnea: a dose increment and pharmacovigilance study.J Pain Symptom Manage2011; 42(3): 388–399. doi: 10.1016/j.jpainsymman.2010.11.021.
73.
EkströmM.P., Bornefalk-HermanssonA., AbernethyA.P.Safety of benzodiazepines and opioids in very severe respiratory disease: national prospective studyBMJ2014; 348: g445. doi: 10.1136/bmj.g445.
74.
SimonS.T., HigginsonI.J., BoothS.Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in adults.Cochrane Database Syst Rev2010; 1: CD007354. doi: 10.1002/14651858.CD007354.pub2.
75.
McDonaldC.F., BlythC.M., LazarusM.D.Exertional oxygen of limited benefit in patients with chronic obstructive pulmonary disease and mild hypoxemia.Am J Respir Crit Care Med1995; 152(5 Pt 1): 1616–1619.
76.
CranstonJ.M., CrockettA., CurrowD.Oxygen therapy for dyspnoea in adults.Cochrane Database Syst Rev2008; 3: CD004769. doi: 10.1002/14651858.CD004769.pub2.
77.
UronisH.E., CurrowD.C., McCroryD.C.Oxygen for relief of dyspnoea in mildly- or non-hypoxaemic patients with cancer: a systematic review and meta-analysis.Br J Cancer2008; 98(2): 294–299. doi: 10.1038/sj.bjc.6604161.
78.
MooreR.P., BerlowitzD.J., DenehyL.A randomised trial of domiciliary, ambulatory oxygen in patients with COPD and dyspnoea but without resting hypoxaemia.Thorax2011; 66(1): 32–37. doi: 10.1136/thx.2009.132522.
SomfayA., PorszaszJ., LeeS.M.Dose-response effect of oxygen on hyperinflation and exercise endurance in nonhypoxaemic COPD patients.Eur Respir J2001; 18(1): 77–84.
81.
SwinburnC.R., WakefieldJ.M., JonesP.W.Relationship between ventilation and breathlessness during exercise in chronic obstructive airways disease is not altered by prevention of hypoxaemia.Clin Sci (Lond)1984; 67(5): 515–519.
82.
AbernethyA.P., McDonaldC.F., FrithP.A.Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnoea: a double-blind, randomised controlled trial.Lancet2010; 376(9743): 784–793. doi: 10.1016/S0140-6736(10)61115-4.
83.
LissH.P., GrantB.J.The effect of nasal flow on breathlessness in patients with chronic obstructive pulmonary disease.Am Rev Respir Dis1988; 137(6): 1285–1288.
84.
SmollerJ.W., PollackM.H., OttoM.W.Panic anxiety, dyspnea, and respiratory disease. Theoretical and clinical considerations.Am J Respir Crit Care Med1996; 154(1): 6–17.
85.
PappL.A., WeissJ.R., GreenbergH.E.Sertraline for chronic obstructive pulmonary disease and comorbid anxiety and mood disorders.Am J Psychiatry1995; 152(10): 1531.
86.
RaynerL., PriceA., EvansA.Antidepressants for the treatment of depression in palliative care: systematic review and meta-analysis.Palliat Med2011; 25(1): 36–51. doi: 10.1177/0269216310380764.
87.
CornerJ., PlantH., A'HernR., BaileyC.Non-pharmacological intervention for breathlessness in lung cancer.Palliat Med1996; 10(4): 299–305.
88.
BoothS., MoffatC., FarquharM.Developing a breathless-ness intervention service for patients with palliative and supportive care needs, irrespective of diagnosis.J Palliat Care2011; 27(1): 28–36.
89.
ConnorsS., GrahamS., PeelT.An evaluation of a physiotherapy led non-pharmacological breathlessness programme for patients with intrathoracic malignancy.Palliat Med2007; 21(4): 285–287.
90.
FarquharM., HigginsonI.J., FaganP.Results of a pilot investigation into a complex intervention for breathlessness in advanced chronic obstructive pulmonary disease (COPD): brief report.Palliat Support Care2010; 8(02): 143–149.
91.
BoothS., FarquharM., GyselsM.The impact of a breath-lessness intervention service (BIS) on the lives of patients with intractable dyspnea: a qualitative phase 1 study.Palliat Support Care2006; 4(3): 287–293. doi: 10.1017/S1478951509990897.
92.
BauseweinC., JolleyC., ReillyC.Development, effectiveness and cost-effectiveness of a new out-patient Breathless-ness Support Service: study protocol of a phase III fast-track randomised controlled trial.BMC Pulm Med2012; 12: 58. doi: 10.1186/1471-2466-12-58.
93.
FarquharM.C., PrevostA.T., McCroneP.Study protocol: phase III single-blinded fast-track pragmatic randomised controlled trial of a complex intervention for breathlessness in advanced disease.Trials2011; 12: 130. doi: 10.1186/1745-6215-12-130.
94.
WilliamsM.Applicability and generalizability of palliative interventions for dyspnoea: one size fits all, some or none?Curr Opin Support Palliat Care2011; 5(2): 92–100. doi: 10.1097/SPC.0b013e328345d4a1.
95.
MaddocksM., MockettS., WilcockA.Is exercise an acceptable and practical therapy for people with or cured of cancer? A systematic review.Cancer Treat Rev2009; 35(4): 383–390. doi: 10.1016/j.ctrv.2008.11.008.
96.
PuhanM.A., Gimeno-SantosE., ScharplatzM.Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease.Cochrane Database Syst Rev2011; 10: CD005305. doi: 10.1002/14651858.CD005305.pub3.
97.
SachsS., WeinbergR.L.Pulmonary rehabilitation for dyspnea in the palliative-care setting.Curr Opin Support Palliat Care2009; 3(2): 112–119. doi: 10.1097/SPC.0b013e32832b7248.
98.
RetickerA.L., NiciL., ZuWallackR.Pulmonary rehabilitation and palliative care in COPD: two sides of the same coin?Chron Respir Dis2012; 9(2): 107–116. doi: 10.1177/14799723 12441379.
99.
JanssenD.J.A., McCormickJ.R.Palliative care and pulmonary rehabilitation.Clin Chest Med2014; 35(2): 411–421. doi: 10.1016/j.ccm.2014.02.006.
100.
Rice TalbotH., MalcolmL., NormanK.An evaluation of the St Christopher's Hospice rehabilitation gym circuits classes: patient uptake, outcomes, and feedback.Prog Palliat Care2014 [special issue article]. doi: 10.1179/1743291X14Y.0000000083.